or Try an Advanced Search...

    Technical Analysis for ACET - Adicet Bio, Inc.

    Grade Last Price % Change Price Change
    F 1.63 -5.78% -0.10
    ACET closed up 2.37 percent on Tuesday, May 7, 2024, on 1.13 times normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical ACET trend table...
    Date Alert Name Type % Chg
    Earnings Movers Other -5.78%
    Wide Bands Range Expansion -5.78%
    Up 3 Days in a Row Strength -5.78%
    Oversold Stochastic Weakness -5.78%
    Wide Bands Range Expansion -3.55%
    Oversold Stochastic Weakness -3.55%
    Volume Surge Other 12.41%
    Wide Bands Range Expansion 12.41%
    Oversold Stochastic Weakness 12.41%
    Volume Surge Other 15.60%
    Older End-of-Day Signals for ACET ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 25 minutes ago
    60 Minute Opening Range Breakdown about 2 hours ago
    Down 3% about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    1.5x Volume Pace about 3 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ACET Chart by TradingView
    Basic chart:

    Profile

    Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell T Cell Therapies For Cancer Chimeric Antigen Receptor Adoptive Cell Transfer Antigen Immune Response

    Is ACET a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
    Apr 30 Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    Apr 22 Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
    Apr 8 Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
    Mar 21 Are Investors Undervaluing Adicet Bio, Inc. (NASDAQ:ACET) By 41%?
    Mar 19 Adicet Bio: Q4 Earnings Insights
    Mar 19 Adicet Bio GAAP EPS of -$0.69 beats by $0.01
    Mar 19 Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
    Mar 11 Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
    Feb 13 Jones upgrades Adicet to buy, cites upcoming catalysts
    See more ACET news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.5
    52 Week Low 1.1
    Average Volume 1,425,001
    200-Day Moving Average 1.96
    50-Day Moving Average 2.11
    20-Day Moving Average 1.88
    10-Day Moving Average 1.62
    Average True Range 0.17
    RSI (14) 43.18
    ADX 18.06
    +DI 24.37
    -DI 28.52
    Chandelier Exit (Long, 3 ATRs) 1.83
    Chandelier Exit (Short, 3 ATRs) 1.91
    Upper Bollinger Bands 2.44
    Lower Bollinger Band 1.31
    Percent B (%b) 0.37
    BandWidth 60.20
    MACD Line -0.18
    MACD Signal Line -0.17
    MACD Histogram -0.0132
    Fundamentals Value
    Market Cap 141.95 Million
    Num Shares 82.1 Million
    EPS -3.35
    Price-to-Earnings (P/E) Ratio -0.52
    Price-to-Sales 14.00
    Price-to-Book 1.38
    PEG Ratio 0.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.04
    Resistance 3 (R3) 2.05 1.96 1.99
    Resistance 2 (R2) 1.96 1.88 1.95 1.97
    Resistance 1 (R1) 1.84 1.83 1.90 1.83 1.95
    Pivot Point 1.75 1.75 1.78 1.75 1.75
    Support 1 (S1) 1.64 1.67 1.70 1.63 1.51
    Support 2 (S2) 1.55 1.62 1.54 1.49
    Support 3 (S3) 1.43 1.55 1.47
    Support 4 (S4) 1.42